等待开盘 02-07 09:30:00 美东时间
+1.035
+3.05%
Axogen stock fell Thursday with a session volume of 1.92 million, priced its upsized underwritten public offering at $31.00 per share.
01-23 01:42
Axogen, Inc. announced that its CEO, Michael Dale, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 11, 2025. The event will be live streamed on Axogen's website and available for replay for 90 days. Axogen focuses on developing innovative solutions for peripheral nerve regeneration and repair, offering a range of products to address diverse patient needs.
2025-05-28 12:00